Entresto and Ceftriaxone drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Entresto (sacubitril; valsartan) and Ceftriaxone (ceftriaxone sodium). Common drug interactions include sepsis among females and dyspnoea among males.
The phase IV clinical study analyzes what interactions people have when they take Entresto and Ceftriaxone. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.
What is Entresto?
Entresto has active ingredients of sacubitril; valsartan. eHealthMe is studying from 126,628 Entresto users. Check the latest studies of Entresto.
What is Ceftriaxone?
Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 40,991 Ceftriaxone users. Check the latest studies of Ceftriaxone.
51 people who take Entresto and Ceftriaxone together, and have interactions are studied.

What are the common drug interactions of Entresto and Ceftriaxone, by gender? *:
female:
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
- Asthenia (weakness)
- Blood lactic acid increased
- Clostridium test positive
- Diarrhoea
- Lethargy (tiredness)
- Malaise (a feeling of general discomfort or uneasiness)
- Pain in extremity
male:
- Dyspnoea (difficult or laboured respiration)
- Abdominal distension
- Cardiac failure congestive
- Cough
- Head injury
- Loss of consciousness
- Cardiac failure
- Haematemesis (vomiting of blood)
- Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
What are the common drug interactions of Entresto and Ceftriaxone, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Dyspnoea (difficult or laboured respiration)
- Abdominal distension
- Pneumonia
- Cardiac failure congestive
- Head injury
- Loss of consciousness
- Cardiac failure
- Haematemesis (vomiting of blood)
- Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
What are the existing conditions these people have? *
- Cardiac Failure: 18 people, 35.29%
- Parkinson's Disease: 5 people, 9.80%
- Pain: 5 people, 9.80%
- Lung Disorder (lung disease): 5 people, 9.80%
- Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 5 people, 9.80%
- Anaemia (lack of blood): 5 people, 9.80%
- Diabetes: 4 people, 7.84%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 7.84%
- Infection: 3 people, 5.88%
- Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Entresto and Ceftriaxone?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Entresto (126,628 reports)
- Ceftriaxone (40,991 reports)
Browse all drug interactions of Entresto and Ceftriaxone:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Entresto:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ceftriaxone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Entresto and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ceftriaxone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on sacubitril; valsartan and ceftriaxone sodium (the active ingredients of Entresto and Ceftriaxone, respectively), and Entresto and Ceftriaxone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Famotidine cause Consciousness - Decreased? - now
- Drug interactions of Lupron and Robaxin - 4 seconds ago
- Could Paracetamol cause Appetite Disorder? - 15 seconds ago
- Diabetes Mellitus Inadequate Control and Gallstones - 22 seconds ago
- Peripheral Swelling and Musculoskeletal Chest Pain - 31 seconds ago
- Could Xyzal cause Blood Glucose Decreased? - 37 seconds ago
- Could Zocor cause Vasospasm? - 37 seconds ago
- Could Lupaneta Pack cause Nausea Aggravated? - 47 seconds ago
- Could Albuterol Sulfate cause Hypokinesia? - 52 seconds ago
- Lotrel and Sleep Apnoea Syndrome for Men aged 30-39 - 54 seconds ago